228 related articles for article (PubMed ID: 12413342)
21. Neonatal complications after intrauterine exposure to SSRI antidepressants.
Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
[TBL] [Abstract][Full Text] [Related]
22. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
23. Prolonged neonatal complications after in utero exposure to fluoxetine.
Alehan F; Saygi S; Tarcan A; Gürakan B
J Matern Fetal Neonatal Med; 2008 Dec; 21(12):921-3. PubMed ID: 18985556
[TBL] [Abstract][Full Text] [Related]
24. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
[TBL] [Abstract][Full Text] [Related]
25. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
26. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
[TBL] [Abstract][Full Text] [Related]
27. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.
Bakker MK; Kerstjens-Frederikse WS; Buys CH; de Walle HE; de Jong-van den Berg LT
Birth Defects Res A Clin Mol Teratol; 2010 Feb; 88(2):94-100. PubMed ID: 19937603
[TBL] [Abstract][Full Text] [Related]
28. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].
Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML
Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198
[TBL] [Abstract][Full Text] [Related]
29. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
Koren G; Matsui D; Einarson A; Knoppert D; Steiner M
CMAJ; 2005 May; 172(11):1457-9. PubMed ID: 15911861
[No Abstract] [Full Text] [Related]
30. [SSRIs and pregnancy: a review of the literature].
Soufia M; Aoun J; Gorsane MA; Krebs MO
Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
[TBL] [Abstract][Full Text] [Related]
31. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.
Sanz EJ; De-las-Cuevas C; Kiuru A; Bate A; Edwards R
Lancet; 2005 Feb 5-11; 365(9458):482-7. PubMed ID: 15705457
[TBL] [Abstract][Full Text] [Related]
32. Paroxetine in the first trimester and the prevalence of congenital malformations.
Cole JA; Ephross SA; Cosmatos IS; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1075-85. PubMed ID: 17729379
[TBL] [Abstract][Full Text] [Related]
33. Defective alleles may not have contributed to adverse effects.
Stiskal JA
Ther Drug Monit; 2006 Feb; 28(1):142; author reply 143. PubMed ID: 16418712
[No Abstract] [Full Text] [Related]
34. Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.
Murray KL; Miller KM; Pearson DL
J Perinatol; 2007 Aug; 27(8):517-8. PubMed ID: 17653218
[TBL] [Abstract][Full Text] [Related]
35. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
[TBL] [Abstract][Full Text] [Related]
36. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.
Rampono J; Simmer K; Ilett KF; Hackett LP; Doherty DA; Elliot R; Kok CH; Coenen A; Forman T
Pharmacopsychiatry; 2009 May; 42(3):95-100. PubMed ID: 19452377
[TBL] [Abstract][Full Text] [Related]
37. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?
Isbister GK; Dawson A; Whyte IM; Prior FH; Clancy C; Smith AJ
Arch Dis Child Fetal Neonatal Ed; 2001 Sep; 85(2):F147-8. PubMed ID: 11561552
[No Abstract] [Full Text] [Related]
38. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
[TBL] [Abstract][Full Text] [Related]
39. [Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalopathy?].
Herbst F; Gortner L
Z Geburtshilfe Neonatol; 2003; 207(6):232-4. PubMed ID: 14689334
[TBL] [Abstract][Full Text] [Related]
40. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
